The Semelil (ANGIPARS™) ameliorates cardiac functional disturbances after Permanent Left Anterior Descending Coronary Artery Occlusion Model in rabbit
The Semelil (ANGIPARS™) ameliorates cardiac functional disturbances after Permanent Left Anterior Descending Coronary Artery Occlusion Model in rabbit
Abouzar Talakoub1 Abolghasem Nabipour2 Mohsen Maleki3 Majid Asadi-Shekaari4 Mostafa Latifpour5 Hamid Reza Khorramkhorshid6
1) Department of Basic sciences, Ferdowsi University of Mashhad, Iran, E-Mail:
2) Department of Basic sciences, Ferdowsi University of Mashhad, Iran E-Mail: and
3) Department of Pathobiology, Ferdowsi University of Mashhad, Iran, E-Mail:
4) Department of Anatomy, Faculty of Medicine, Medical University of Medical Sciences, Kerman, Iran, E-Mail:
5) ., Department of Anatomy, Tehran University of Medical Sciences, Tehran, Iran, E-Mail:
6) Genetic Research Center, Social Welfare and Rehabilitation Sciences University, Tehran, Iran, E-Mail:
IOI Code
:
XYDK-AHAFZ
Publication :
International Conference On Research Science And Technology(restconf.com)
Abstract :
Myocardial infarction (MI) is one of the important causes of mortality in all populations.
Some herbal drugs have been utilized for the treatment of MI. This research was designed to
study the cardioprotective effects of Semelil (ANGIPARS™), a novel herbal drug, in male
rabbits. Twenty-five New Zealand white rabbits were randomly allocated into five groups:
control vehicle; sham; sham vehicle; ischemia vehicle; Semelil 10 mg/kg. Ischemia was
created by complete occlusion of Left Anterior Descending Coronary Artery (LADC).
Semelil drug was intraperitoneally injected for two weeks in the treatment group. Functional,
Biochemical, and histological investigations were used for discovering protective effects of
Semelil. Based on our information, Semelil ameliorated the ECHO pattern. In addition,
treatment with Semelil amended levels of serum glutamate oxaloacetate transaminase, serum
glutamate pyruvate transaminase and Cardiac troponin T comparing to the ischemia group.
Morphological data revealed that Semelil could keep cardiomyocyte against myocardial
infarction abuses. The results indicate that Semelil has cardio-protective effects that may be
mediated by anti-inflammatory and anti-oxidant effects.
Keywords : myocardial infarction cardiac enzyme cardiac function semelil